The Food and Drug Administration is outlining a plan to ensure the U.S. supply of baby formula stays constant and safe.
It includes identifying risks to supply chains and developing plans to make disruptions less severe.
The strategy comes as the Biden Administration faces criticism for its handling of the 2022 baby formula shortage.